Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

Details

Language :

English

ISSN :

0732183X

Volume :

26

Issue :

11

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105736657

Full Text :

https://doi.org/10.1200/JCO.2007.14.5375